Grassley Praises House Action Advancing Bills to Reduce Prescription Drug Costs
WASHINGTON – The House Energy and Commerce Committee approved by a vote of 51-0 its version of the CREATES Act, which is cosponsored in the Senate by Finance Committee Chairman Chuck Grassley. The CREATES Act addresses abuses by brand-name drug companies that keep lower-cost generic alternatives from being developed or reaching the market. The legislation […]
Grassley on Requests for the President’s Tax Returns
Prepared Floor Statement by Sen. Chuck Grassley of Iowa Chairman, U.S. Senate Committee on Finance On Requests for the President’s Tax Returns Thursday, April 4, 2019 Mr. President, Yesterday, the Chairman of the Ways and Means Committee sent a letter to the IRS requesting the President’s tax returns. Last night, I had […]
Grassley Op-ed: Stop kicking Medicaid’s safety net hospital payments down the road
Stop kicking Medicaid’s safety net hospital payments down the road By U.S. Senator Chuck Grassley of Iowa Budget scorekeepers tell us that taxpayers spent at least $600 billion in 2017 to pay for health care services for low-income Americans covered by Medicaid. This public health insurance program is a federal-state partnership that pays hospitals, […]
Grassley on the Retirement Enhancement and Savings Act of 2019
Prepared Remarks by U.S. Sen. Chuck Grassley of Iowa Chairman, U.S. Senate Finance Committee On the Retirement Enhancement and Savings Act of 2019 Wednesday, April 3, 2019 VIDEO Mr. President, earlier this week I introduced the bipartisan Retirement Enhancement and Savings Act of 2019 – or the RESA bill as we call it in […]
Grassley Statement on Cigna Insulin Price Announcement
WASHINGTON – U.S. Senate Finance Committee Chairman Chuck Grassley of Iowa today released the following statement regarding an announcement from Cigna (Express Scripts) to cap out-of-pocket costs for insulin prescriptions for some patients. “Any time out-of-pocket prescription drug costs are lowered, that’s good news for patients. But it’s unclear why this is only happening […]
Grassley, Wyden: Payments in College Admission Scandal May Violate Tax Laws
WASHINGTON – U.S. Senate Finance Committee Chairman Chuck Grassley of Iowa and Ranking Member Ron Wyden of Oregon are calling on the IRS to fully enforce the tax laws against those involved in the recent college admissions scandal. Based on information in Department of Justice documents, parents of prospective students appear to have made purported […]
Grassley, Wyden Probe Reports of Abuse at Group Homes in Iowa & Oregon
WASHINGTON – U.S. Senate Finance Committee Chairman Chuck Grassley of Iowa and Ranking Member Ron Wyden of Oregon are requesting information from two companies affiliated with The MENTOR Network (Mentor) after recent news reports in Iowa and Oregon revealed multiple instances of abuse and neglect, and in one case, an apparent death. Mentor contracts […]
Grassley, Bennet Bill to Improve Care for Kids with Complex Medical Conditions Passes Congress
WASHINGTON – Bipartisan legislation to improve health outcomes and care coordination for children with complex medical conditions in Medicaid, led by U.S. Senate Finance Committee Chairman Chuck Grassley of Iowa and Sen. Michael Bennet of Colorado, unanimously passed in the Senate after passing the House of Representatives last week. “Since the start of Medicaid, more […]
Grassley, Wyden Praise Congressional Passage of Right Rebate Act
WASHINGTON – U.S. Senate Finance Committee Chairman Chuck Grassley of Iowa and Ranking Member Ron Wyden of Oregon, today celebrated congressional passage of their bill to prevent drug makers from manipulating Medicaid to gouge taxpayers and increase profits by misclassifying their drugs. The legislation was included in a broader package of Medicaid policies, called the […]
Grassley, Wyden Question Role of Middlemen in Skyrocketing Insulin Prices
WASHINGTON – U.S. Senate Finance Committee Chairman Chuck Grassley of Iowa and Ranking Member Ron Wyden of Oregon today sent letters to Cigna Corporation (Express Scripts), CVS Health Corporation and Optum, the three leading pharmacy benefit managers (PBMs), regarding their role in the skyrocketing cost of insulin in the United States. Last month, the […]